Management of Cervical Intraepithelial Neoplasia Grade 2
NCT ID: NCT00733109
Last Updated: 2010-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
90 participants
INTERVENTIONAL
2003-03-31
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN
NCT04057924
Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN
NCT04115787
Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1
NCT00156026
Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age
NCT03177863
Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III)
NCT03241680
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The researchers purpose was to make some comments about the over treatment and the misclassification of CIN 2.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
excision of the lesion
Excision of the lesion
Surgery with Large Loop Excision of Transformation Zone (LLETZ)
espontaneous regression
Follow-up for spontaneous regression of the lesion
Follow-up at last 12 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Excision of the lesion
Surgery with Large Loop Excision of Transformation Zone (LLETZ)
Follow-up for spontaneous regression of the lesion
Follow-up at last 12 months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
61 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundação de Amparo à Pesquisa do Estado de São Paulo
OTHER_GOV
Universidade Cidade de Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
UNICID- School of Medical Sciense
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sylvia F Brenna, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade Cidade de Sao Paulo
Ana C Guedes, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade Cidade de Sao Paulo
Kari J Sirjanen, MD, PhD
Role: STUDY_CHAIR
University of Turku
Luis C Zeferino, MD, PhD
Role: STUDY_DIRECTOR
University of Campinas, Brazil
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Leonor Mendes de Barros Maternity Hospital
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIN 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.